Team Finds New Target for Melanoma Treatment

Published September 16, 2013

Team finds new target for melanoma treatment
David Fisher, M.D., Ph.D., professor and chairman of the Edward Wigglesworth Department of Dermatology, director of the Melanoma Program, and director of Cutaneous Biology at Massachusetts General Hospital, Harvard Medical School, commented, "The study … Read more on Medical Xpress

Cheaper sequencing points cancer drug researchers to 'super responders'
It turns out that two particular gene mutations made her particularly receptive to the treatment. Now, researchers are hoping to study these patients in a new light–important work that could reveal new uses for currently prescribed or shelved … Read more on FierceBiotech

M Gift to Support Geriatric Fracture Care, Orthopaedic Research
“Mr. Wyss' generous gift is a testament to the caliber of the University's outstanding clinical and research endeavors in the orthopedic field and the pioneering work of Steve Kates in addressing geriatric fractures,” said Mark B. Taubman, M.D., dean … Read more on University of Rochester Newsroom

Approved cancer drug potentially could help treat diabetes, Stanford …
The lab of Calvin Kuo, MD, PhD, professor of medicine, identified a series of protein interactions that link VEGF inhibitors and blood glucose levels. "We were surprised to find that this drug currently used in patients for cancer treatment had … Read more on EurekAlert (press release)